Virtu Financial LLC Abvc Biopharma, Inc. Transaction History

Virtu Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$2.18 - $3.72 $59,341 - $101,262	-27,221 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.15 - $6.03 $28,657 - $80,373	13,329 Added 95.95%	27,221 $92,000
Q3 2021 Nov 12, 2021	BUY	$2.03 - $5.1 $28,200 - $70,849	13,892 New	13,892 $32,000

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $17.9M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.